Target intelligence / Profile preview

Immunomodulatory agent

Molecular classification
Other
01

Overview

Immunomodulatory agents are a class of drugs and natural substances that change immune system activity either by stimulating or suppressing immune responses. They function via a range of molecular mechanisms including modulation of cytokines, inhibition or activation of immune cell functions, and alteration of intracellular signaling pathways. These agents are used to treat diverse conditions such as autoimmune diseases, inflammatory disorders, cancer, infection, and to prevent organ rejection after transplantation. The group includes traditional small molecule immunosuppressants (e.g., methotrexate, azathioprine), monoclonal antibodies, biologics, and some food or natural compounds. Because "immunomodulatory agent" does not specify a single target, it is a functional drug class rather than a molecular target for therapeutic exploitation.

Other names
Immunomodulatorimmunosuppressantimmunostimulantimmune modulatorbiological response modifier
02

Mechanism of action

Suppression or stimulation of immune cell activity; Modulation of cytokine signaling (e.g., by acting on TNF-α, ILs, interferons); Inhibition of T cell activation or proliferation; DNA synthesis inhibition in immune cells (e.g., purine synthesis inhibitors); Blockade or stimulation of specific intracellular signaling pathways (e.g., NF-κB, JAK-STAT)

03

Biological functions

Immune response modulation (including stimulation or suppression of immune pathway activity)Regulation of cytokine productionModulation of immune cell proliferation, differentiation, activation, and migration
04

Disease associations

CancerAutoimmune disorderInflammationInfectionOrgan transplantationAllergic disease
05

Safety considerations

Increased risk of infection due to immune suppressionRisk of malignancy with long-term use of some agentsOrgan toxicity (liver, kidney, bone marrow suppression depending on drug)Potential development of drug resistance or secondary autoimmunity
06

Biomarkers

There are no specific biomarkers for "immunomodulatory agent" as a class; biomarkers are target- and drug-specific, e.g., C-reactive protein for inflammation, immune cell counts, or drug-specific companion diagnostics

Beyond the preview

Go deeper on Immunomodulatory agent.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunomodulatory agent.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call